Rankings Food, drinks & restaurants Beiersdorf

Beiersdorf

Food, drinks & restaurants · GermanyRank 424 of 829Prices 3 Nov 2026Model 1.4

A good business with a real question mark: the price, a crack, or both.

Biggest deductions

  • Quality of growth−6
  • Margin−4
  • Peers−3

Strengths

  • Net cash+2
  • Strong derma brands+1

How the score is built

From 100 to 60, step by step: points off for the business, the price and the cracks, back for documented strengths, then three data adjustments.

100Start
60Score

Hover or select a step to see what drove it. Steps with findings open them below.

Key numbers

As of 3 Nov 2026. Analyst targets tend to be optimistic; read upside as a hint, not a forecast.

Price
83.50 EUR
Median analyst target
81.50 EUR
Upside to median
−2.4%
Analysts
21
Target range
68.00 – 95.00 EUR
52-week change
−9%
P/E (trailing)
19.5
Forward P/E
21.3
PEG
10.51

Findings

Every deduction and every plus, with its source. Open a step to read them.

Business

Is the company getting stronger, not just bigger? · 4 findings
−13 of −30
  • Quality of growth
    Organic sales −3.5% in H1 2026 (Consumer −4.0%, Nivea −6.8%); revenue has fallen from EUR 9.85bn in 2024–2025 to 9.62bn TTM, and the full year 2026 is now expected with a low single-digit organic decline vs previously flat to weak growth.
    −6
  • Margin
    Group EBIT margin guidance cut from 'slightly below 14.0%' to at least 11.8% (Consumer at least 11.0% vs 13.6% last year) because about EUR 100m extra must be spent on Nivea; analysts expect EPS of EUR 3.80 in 2026 vs 4.44 in 2025 (−14%).
    −4
  • Moat and pricing power
    The turnaround plan for Nivea is meant to create volume through cheaper, locally adapted products – a signal that the core brand has lost pricing power against competitors.
    −2
  • Capital allocation and FCF
    The FCF margin has been only 2.8–8.1% in 2021–2025 due to heavy investments; buybacks and dividends (EUR 578m TTM, 724m in 2025) exceeded FCF after leases (516m TTM, 245m in 2025) and are paid from net cash.
    −1

Price

Today's multiples against the company's own history and its peers. · 3 findings
−8 of −35
  • Multiples vs own history
    Forward P/E 20.1 is at the bottom of its own history (20.3–31.0 in 2021–2025) and EV/EBITDA 8.7 below 11.5–18.3, but earnings fall 14% this year, so the low multiple is not a real discount.
    −2
  • Peers
    Forward P/E 20.1 vs 16.3 for Unilever and 27.0 for L'Oréal; Beiersdorf trades at a premium to Unilever, even though the operating margin is 13.6% vs about 20% at both peers and sales are shrinking.
    −3
  • Absolute price level
    FCF yield 3.5% (P/FCF 28.9) and about 3.0% after leases; dividend yield 1.3%.
    −3

Cracks

Cash flow, customers, debt, insiders, guidance and what sits behind the headline numbers. · 3 findings
−6 of −35
  • Execution of the turnaround
    Second phase of the Nivea restructuring after the recovery proceeded more slowly than expected; delivery problems and inventory reduction at retailers hit, growth is not expected until 2027, and Bernstein expects consensus estimates about 15% lower.
    −3
  • Governance and control
    Only 89 of 218m shares (41%) are free float; the major shareholder maxingvest (the Herz family) has control, and minority shareholders have limited influence.
    −2
  • Regulation
    The CEO himself warns of EU over-regulation of cosmetics and chemicals, which may increase costs for the industry.
    −1

Plus

Only documented strengths. · 2 findings
+3 of +15
  • Net cash
    Net cash EUR 2.73bn (16% of market value), debt/equity 0.01 and current ratio 2.0.
    +2
  • Strong derma brands
    Derma (Eucerin, Aquaphor) and Healthcare grew in H1 despite the Nivea decline; tesa turned to +2.5% organic in Q2.
    +1

Caveats

What the score does not capture, or where the data is weak.
Skin care (Nivea, Eucerin, La Prairie) and adhesive tape (tesa, about 17% of sales) do not fit the industrial list: placed under 'Consumer: food, beverages & restaurants' as the nearest consumer-goods category. Trailing P/E (18.3) is lower than forward P/E (20.1) because analysts expect EPS −14% in 2026. La Prairie/China, Derma growth figures and insider trades have not been examined (web limit reached). Q3 report 27 Oct 2026.

Also in Food, drinks & restaurants

The highest scores in the same industry.

Whole industry